Wu W, Zhang X, Qi X
Molecular Medical Center, Second Affiliated Hospital, Jiangxi Medical College, Nanchang 330006, China.
Zhonghua Jie He He Hu Xi Za Zhi. 2000 Jul;23(7):403-5.
To investigate the effect of tumor suppressor gene p53 and(or) p16 treatment on the nude mice models of non-small cell lung cancer (NSCLC).
Nude mice were injected subcutaneously with NSCLC cell line A549. 25 nude mice were randomly divided into 5 groups (control, SA, p53 gene, p16 gene, p53 + p16 genes), p53 and(or) p16 genes mediated by stearylamine/DOPE (SA liposome) were injected intratumorally alone or jointly. The size of tumor and survival period of nude mice were measured after treatment.
p53 and(or) p16 genes can obviously inhibit the growth of tumor. The difference was significant between control and treated groups, among which the combined p53 and p16 genes enhance the inhibiting effect more markedly. The survival period of tumor-bearing nude mice was prolonged after transfecting p53 gene or p16 gene alone, p53 and p16 genes jointly can prolong the survival period significantly.
Tumor suppressor gene p53 and(or) p16 in the replacement therapy of NSCLC are of potential clinical significance. The combination of p53 and p16 gene may have a greater antitumoral effect in vivo.
探讨抑癌基因p53和(或)p16治疗对非小细胞肺癌(NSCLC)裸鼠模型的影响。
将NSCLC细胞系A549皮下注射到裸鼠体内。25只裸鼠随机分为5组(对照组、SA组、p53基因组、p16基因组、p53 + p16基因组),单独或联合瘤内注射由硬脂胺/二油酰磷脂酰乙醇胺(SA脂质体)介导的p53和(或)p16基因。治疗后测量裸鼠肿瘤大小和生存期。
p53和(或)p16基因可明显抑制肿瘤生长。对照组与治疗组之间差异显著,其中p53和p16基因联合使用时抑制作用更明显。单独转染p53基因或p16基因后,荷瘤裸鼠的生存期延长,p53和p16基因联合使用可显著延长生存期。
抑癌基因p53和(或)p16在NSCLC替代治疗中具有潜在的临床意义。p53和p16基因联合使用在体内可能具有更大的抗肿瘤作用。